1 - 25 of
28
results
for author:"Hoskins J."
in Literature Citations
| Pharmacodynamic genes do not influence risk of neutropenia in cancer patients treated with moderately high-dose irinotecan. Hoskins J.M., Rosner G.L., Ratain M.J., McLeod H.L., Innocenti F. Pharmacogenomics 10:1139-1146(2009) · Mapped (25) |
| Influence of ethnicity on pharmacogenetic variation in the Ghanaian population. Yen-Revollo J.L., Van Booven D.J., Peters E.J., Hoskins J.M., Engen R.M., Kannall H.D., Ofori-Adjei D., McLeod H.L., Marsh S. Pharmacogenomics J. 0:0-0(2009) · Mapped (84) |
| Properties of Nat4, an N(alpha)-acetyltransferase of Saccharomyces cerevisiae that modifies N termini of histones H2A and H4. Polevoda B., Hoskins J., Sherman F. Mol. Cell. Biol. 29:2913-2924(2009) · Mapped (8) |
| Loss of metal ions, disulfide reduction and mutations related to familial ALS promote formation of amyloid-like aggregates from superoxide dismutase. Oztug Durer Z.A., Cohlberg J.A., Dinh P., Padua S., Ehrenclou K., Downes S., Tan J.K., Nakano Y., Bowman C.J., Hoskins J.L. et al. PLoS ONE 4:e5004-e5004(2009) · Mapped (1) |
| The significance of disulfide bonding in biological activity of HB-EGF, a mutagenesis approach. Hoskins J.T., Zhou Z., Harding P.A. Biochem. Biophys. Res. Commun. 375:506-511(2008) · Mapped (4) |
| RNA-based 5-fluorouracil toxicity requires the pseudouridylation activity of Cbf5p. Hoskins J., Butler J.S. Genetics 179:323-330(2008) · Mapped (2) |
| Irinotecan pharmacogenetics: influence of pharmacodynamic genes. Hoskins J.M., Marcuello E., Altes A., Marsh S., Maxwell T., Van Booven D.J., Pare L., Culverhouse R., McLeod H.L., Baiget M. Clin. Cancer Res. 14:1788-1796(2008) · Mapped (29) |
| Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphisms and toxicity to capecitabine in advanced colorectal cancer patients. Sharma R., Hoskins J.M., Rivory L.P., Zucknick M., London R., Liddle C., Clarke S.J. Clin. Cancer Res. 14:817-825(2008) · Mapped (15) |
| UGT1A1*28 genotype and irinotecan-induced neutropenia: dose matters. Hoskins J.M., Goldberg R.M., Qu P., Ibrahim J.G., McLeod H.L. J. Natl. Cancer Inst. 99:1290-1295(2007) · Mapped (6) |
| Evidence for distinct DNA- and RNA-based mechanisms of 5-fluorouracil cytotoxicity in Saccharomyces cerevisiae. Hoskins J., Scott Butler J. Yeast 24:861-870(2007) · Mapped (8) |
| Imatinib disposition and ABCB1 (MDR1, P-glycoprotein) genotype. Gurney H., Wong M., Balleine R.L., Rivory L.P., McLachlan A.J., Hoskins J.M., Wilcken N., Clarke C.L., Mann G.J., Collins M. et al. Clin. Pharmacol. Ther. 82:33-40(2007) · Mapped (8) |
| Asymmetric deceleration of ClpB or Hsp104 ATPase activity unleashes protein-remodeling activity. Doyle S.M., Shorter J., Zolkiewski M., Hoskins J.R., Lindquist S.L., Wickner S. Nat. Struct. Mol. Biol. 14:114-122(2007) · UniProtKB (1) |
| Relationship of hepatic functional imaging to irinotecan pharmacokinetics and genetic parameters of drug elimination. Michael M., Thompson M., Hicks R.J., Mitchell P.L., Ellis A., Milner A.D., Di Iulio J., Scott A.M., Gurtler V., Hoskins J.M. et al. J. Clin. Oncol. 24:4228-4235(2006) · Mapped (9) |
| 5-fluorouracil enhances exosome-dependent accumulation of polyadenylated rRNAs. Fang F., Hoskins J., Butler J.S. Mol. Cell. Biol. 24:10766-10776(2004) · Mapped (1) |
| CbpA, a DnaJ homolog, is a DnaK co-chaperone, and its activity is modulated by CbpM. Chae C., Sharma S., Hoskins J.R., Wickner S. J. Biol. Chem. 279:33147-33153(2004) · UniProtKB (2) |
| Concordance between proguanil phenotype and CYP2C19 genotype in Chinese. Hoskins J.M., Shenfield G.M., Gross A.S. Eur. J. Clin. Pharmacol. 59:611-614(2003) · Mapped (3) |
| Genome of the bacterium Streptococcus pneumoniae strain R6. Hoskins J., Alborn W.E. Jr., Arnold J., Blaszczak L.C., Burgett S., DeHoff B.S., Estrem S.T., Fritz L., Fu D.-J., Fuller W. et al. J. Bacteriol. 183:5709-5717(2001) · UniProtKB (2,029) |
| Gene disruption studies of penicillin-binding proteins 1a, 1b, and 2a in Streptococcus pneumoniae. Hoskins J., Matsushima P., Mullen D.L., Tang J., Zhao G., Meier T.I., Nicas T.I., Jaskunas S.R. J. Bacteriol. 181:6552-6555(1999) · UniProtKB (2) |
| Identification, purification, and characterization of transpeptidase and glycosyltransferase domains of Streptococcus pneumoniae penicillin-binding protein 1a. Di Guilmi A.M., Mouz N., Andrieu J.P., Hoskins J., Jaskunas S.R., Gagnon J., Dideberg O., Vernet T. J. Bacteriol. 180:5652-5659(1998) · Mapped (1) |
| Crystal structure of calcium-independent subtilisin BPN' with restored thermal stability folded without the prodomain. Almog O., Gallagher T., Tordova M., Hoskins J., Bryan P., Gilliland G.L. Proteins 31:21-32(1998) · Mapped (1) |
| Cloning and characterization of femA and femB from Staphylococcus epidermidis. Alborn W.E. Jr., Hoskins J., Uenal S., Flokowitsch J.E., Hayes C.A., Dotzlaf J.E., Yeh W.K., Skatrud P.L. Gene 180:177-181(1996) · UniProtKB (2) |
| Association of intestinal peptide transport with a protein related to the cadherin superfamily. Dantzig A.H., Hoskins J., Tabas L.B., Bright S., Shepard R.L., Jenkins I.L., Duckworth D.C., Sportsman J.R., MacKensen D., Rosteck P.R. Jr. et al. |
| Evolution and organization of the human protein C gene. Plutzky J., Hoskins J.A., Long G.L., Crabtree G.R. Proc. Natl. Acad. Sci. U.S.A. 83:546-550(1986) · UniProtKB (1) |
| Cloning and characterization of human liver cDNA encoding a protein S precursor. Hoskins J., Norman D.K., Beckmann R.J., Long G.L. Proc. Natl. Acad. Sci. U.S.A. 84:349-353(1987) · UniProtKB (1) |
| Gene disruption of the pcbAB gene encoding ACV synthetase in Cephalosporium acremonium. Hoskins J.A., O'Callaghan N., Queener S.W., Cantwell C.A., Wood J.S., Chen V.J., Skatrud P.L. Curr. Genet. 18:523-530(1990) · UniProtKB (1) |
